Business Description
SLS BIO Co Ltd
ISIN : KR7246250005
Compare
Compare
Traded in other countries / regions
246250.Korea IPO Date
2016-06-29Description
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.11 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 0.74 | |||||
| Interest Coverage | 9.14 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 6.42 | |||||
| Beneish M-Score | -2.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.1 | |||||
| 3-Year EBITDA Growth Rate | 61.7 | |||||
| 3-Year Book Growth Rate | 50.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.84 | |||||
| 9-Day RSI | 40.39 | |||||
| 14-Day RSI | 39.38 | |||||
| 6-1 Month Momentum % | -10.92 | |||||
| 12-1 Month Momentum % | -21.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.39 | |||||
| Quick Ratio | 8.2 | |||||
| Cash Ratio | 6.61 | |||||
| Days Inventory | 15.72 | |||||
| Days Sales Outstanding | 85.79 | |||||
| Days Payable | 24.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.29 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| Forward Dividend Yield % | 1.29 | |||||
| 5-Year Yield-on-Cost % | 1.29 | |||||
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | 2.59 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.52 | |||||
| Operating Margin % | 8.94 | |||||
| Net Margin % | 11.74 | |||||
| FCF Margin % | 11.71 | |||||
| ROE % | 8.58 | |||||
| ROA % | 6.41 | |||||
| ROIC % | 10.88 | |||||
| ROC (Joel Greenblatt) % | 20.14 | |||||
| ROCE % | 7.42 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.9 | |||||
| PE Ratio without NRI | 27.9 | |||||
| Price-to-Owner-Earnings | 12.45 | |||||
| PS Ratio | 3.32 | |||||
| PB Ratio | 2.16 | |||||
| Price-to-Tangible-Book | 2.18 | |||||
| Price-to-Free-Cash-Flow | 28.63 | |||||
| Price-to-Operating-Cash-Flow | 10.55 | |||||
| EV-to-EBIT | 20.09 | |||||
| EV-to-EBITDA | 9.13 | |||||
| EV-to-Revenue | 2.46 | |||||
| EV-to-FCF | 21.19 | |||||
| Price-to-Projected-FCF | 1.18 | |||||
| Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.8 | |||||
| Price-to-Net-Cash | 5.56 | |||||
| Earnings Yield (Greenblatt) % | 4.97 | |||||
| FCF Yield % | 3.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SLS BIO Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 9,019.543 | ||
| EPS (TTM) (â‚©) | 69 | ||
| Beta | 0.84 | ||
| Volatility % | 77.78 | ||
| 14-Day RSI | 39.38 | ||
| 14-Day ATR (â‚©) | 112.02412 | ||
| 20-Day SMA (â‚©) | 1959.1 | ||
| 12-1 Month Momentum % | -21.71 | ||
| 52-Week Range (â‚©) | 1560 - 5430 | ||
| Shares Outstanding (Mil) | 15.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SLS BIO Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SLS BIO Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
SLS BIO Co Ltd Frequently Asked Questions
What is SLS BIO Co Ltd(XKRX:246250)'s stock price today?
The current price of XKRX:246250 is â‚©1925.00. The 52 week high of XKRX:246250 is â‚©5430.00 and 52 week low is â‚©1560.00.
When is next earnings date of SLS BIO Co Ltd(XKRX:246250)?
The next earnings date of SLS BIO Co Ltd(XKRX:246250) is .
Does SLS BIO Co Ltd(XKRX:246250) pay dividends? If so, how much?
The Dividend Yield %  of SLS BIO Co Ltd(XKRX:246250) is 1.29% (As of Today), Highest Dividend Payout Ratio of SLS BIO Co Ltd(XKRX:246250) was 0.36. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of SLS BIO Co Ltd(XKRX:246250) is 1.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers